Press Releases Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 06/02/2026 GMT			5-day change	1st Jan Change
101.85 ^USD	+3.55%		-10.69%	-0.28%

02-02	Guardant Health, Inc. Announces Publication of the Largest Study to Date Evaluating Circulating Tumors forMRD Detection in Patients with Rescted Stage III Colon Cancer After Surgery and Before Adjuvant Chemotherapy	CI
01-30	UBS Adjusts Price Target on Guardant Health to $175 From $110, Maintains Buy Rating	MT

Press Releases

02-03	Guardant Health to Participate in Upcoming Investor Conferences	BU
02-03	Largest Published Study of Molecular Residual Disease in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence after Surgery to Support Timely Treatment Decisions	AQ
02-02	Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions	BU
01-29	Guardant Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026	BU
01-22	Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer	BU
01-19	Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform	BU
01-15	Guardant Health : JP Morgan Healthcare Conference	PU
01-15	Guardant Health : Corporate Governance Guidelines (Corporate Governance Guidelines FINAL as of 10 22 2025)	PU
01-15	Guardant Health : Compensation Committee Charter (Compensation Committee Charter FINAL as of 10 22 2025)	PU
01-11	Guardant Health : Announces Preliminary Fourth Quarter and Full Year 2025 Results	PU
01-11	Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results	BU
01-08	Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families	BU
12-30	Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening	AQ
12-29	Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference	BU
12-11	Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.	BU
12-09	Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy	BU
12-05	Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium	BU
11-12	Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access	BU
11-10	Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring	BU
11-07	Guardant Health to Participate in Upcoming Investor Conferences	BU
11-06	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
11-06	New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response	BU
11-05	Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients	BU
11-05	Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering	BU
11-05	Guardant Health Announces Pricing of Upsized Public Offering of Common Stock	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Press Releases

Filters